MephedroneCandy
Bluelighter
- Joined
- Mar 18, 2022
- Messages
- 88
I ordered 10 grams of S(+)-Deprenyl to treat my ADHD. It is the opposite enantiomer of the MAO-B inhibitor Selegiline.
It is a prodrug for dextromethamphetamine mainly and dextroamphetamine. The metabolism is also very efficient as you get about 75% back in amphetamines.
Through oral ROA in a few hours half gets produced, through others the half life is 20 hours, so dextrometahamphetamine production is extremely stable over the whole 24 hours of the day.
About this substance there are a lot of threads on internet forums from people interested in it, but I didn't saw any experience. I hope to write mine.
Consider everything as dextro enantiomers as the metabolism is stereoselective:
MY OWN RATIONALE:
People with ADHD sleep better on stimulants than without. When sleep is difficult after taking it, it is because they are withdrawal.
ADHD rebound is the most problematic side effect of stimulants and the cause of insomnia. Living everyday through peaks and withdrawals lower the quality of life.
What is normally called comedown in reality is the withdrawal and is the cause of xerostomia, bruxism, stiffness and other side effects.
Vyvanse and other prodrugs had been developed to address this, but they are not available in most countries or they cost a lot.
S(+)-Deprenyl is legal in most countries, altough it is not a research chemical as the drug has been researched a lot for decades.
Also, dextromethamphetamine has higher therapeutic value for a lot of patients than dextroamphetamine, especially considering the side effects.
Dextromethamphetamine is reported to have less cardiovascular side effects than amphetamine even though it has the same DAT/NAT affinity ratio.
This is because dopamine release it is indirecrly potentiated by its sigma1 antagonism propriety since it facilitates DAT reversal.
S(+)-Deprenyl has a very high affinity for sigma1, thus it exalts this favorable mechanism of action and potentiates dopamine release even more.
Selegiline has been shown to be neuroprotective by preventing the damage of short and long term methamphetamine neurotoxicity.
Hopefully, S(+)-Deprenyl still has the ability to inhibit most mao-b enzymes as it would be neuroprotective and increases PEA.
PEA's NDRI properties might counteract amphetamines induced reuptake transporters downregulation.
In the end, it might be a very good prodrug to get EXTREMELY stable h24 stimulation without neurotoxicity nor tolerance!
Any thoughts before it arrives?
en.wikipedia.org
It is a prodrug for dextromethamphetamine mainly and dextroamphetamine. The metabolism is also very efficient as you get about 75% back in amphetamines.
Through oral ROA in a few hours half gets produced, through others the half life is 20 hours, so dextrometahamphetamine production is extremely stable over the whole 24 hours of the day.
About this substance there are a lot of threads on internet forums from people interested in it, but I didn't saw any experience. I hope to write mine.
Consider everything as dextro enantiomers as the metabolism is stereoselective:
MY OWN RATIONALE:
People with ADHD sleep better on stimulants than without. When sleep is difficult after taking it, it is because they are withdrawal.
ADHD rebound is the most problematic side effect of stimulants and the cause of insomnia. Living everyday through peaks and withdrawals lower the quality of life.
What is normally called comedown in reality is the withdrawal and is the cause of xerostomia, bruxism, stiffness and other side effects.
Vyvanse and other prodrugs had been developed to address this, but they are not available in most countries or they cost a lot.
S(+)-Deprenyl is legal in most countries, altough it is not a research chemical as the drug has been researched a lot for decades.
Also, dextromethamphetamine has higher therapeutic value for a lot of patients than dextroamphetamine, especially considering the side effects.
Dextromethamphetamine is reported to have less cardiovascular side effects than amphetamine even though it has the same DAT/NAT affinity ratio.
This is because dopamine release it is indirecrly potentiated by its sigma1 antagonism propriety since it facilitates DAT reversal.
S(+)-Deprenyl has a very high affinity for sigma1, thus it exalts this favorable mechanism of action and potentiates dopamine release even more.
Selegiline has been shown to be neuroprotective by preventing the damage of short and long term methamphetamine neurotoxicity.
Hopefully, S(+)-Deprenyl still has the ability to inhibit most mao-b enzymes as it would be neuroprotective and increases PEA.
PEA's NDRI properties might counteract amphetamines induced reuptake transporters downregulation.
In the end, it might be a very good prodrug to get EXTREMELY stable h24 stimulation without neurotoxicity nor tolerance!
Any thoughts before it arrives?

D-Deprenyl - Wikipedia
Last edited: